Repositioning gemigliptin for the alleviation of thioacetamide-induced liver fibrosis in rats: Targeting TLR4/MAPK, SIRT1/AMPK/Nrf2, PI3K/AKT/mTOR axis and apoptosis

Riyadh S. Almalki(Umm al-Qura University), Marawan A. Elbaset(National Research Centre), Samar F. Miski(Taibah University), Alyaa F. Hessin(National Research Centre), Malaz Gazzaz(Umm al-Qura University), Reda M. S. Korany(Cairo University), Hany M. Fayed(Institute of Clinical Research), Sherif M. Afifi(University of Sadat City), Bassim M. S. A. Mohamed(National Research Centre), Tuba Esatbeyoglu(Gottfried-Wilhelm-Leibniz-Gesellschaft)
European Journal of Pharmaceutical Sciences
July 7, 2025
Cited by 15


Related Papers